High Tower Advisors, LLC Genocea Biosciences, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.01 - $1.38 $2,122 - $292,918	-212,260 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.33 $17 - $23	-10 Reduced -0.0%	212,260 $408,000
Q2 2021 Aug 06, 2021	BUY	$2.06 - $2.82 $4,552 - $6,232	2,210 Added 1.05%	212,270 $496,000
Q3 2020 Nov 13, 2020	BUY	$1.81 - $5.53 $75,250 - $229,909	41,575 Added 24.68%	210,060 $481,000
Q2 2020 Aug 10, 2020	BUY	$1.66 - $3.06 $2,075 - $3,825	1,250 Added 0.75%	168,485 $387,000
Q1 2020 May 21, 2020	BUY	$1.26 - $2.73 $3,780 - $8,190	3,000 Added 1.83%	167,235 $287,000
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $2,050 - $2,820	1,000 Added 0.61%	164,235 $339,000
Q3 2019 Nov 12, 2019	SELL	$2.9 - $4.07 $18,850 - $26,455	-6,500 Reduced 3.83%	163,235 $474,000
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $588,980 - $1.14 Million	169,735 New	169,735 $666,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.